Experts cited by UK outlets say a low-cost urine test can identify biological signals linked to future risk of heart attacks and strokes. The test is described as taking a small sample of urine and being comparatively inexpensive, with reports putting the cost around £6.
The articles also argue that many people may not be offered the test routinely by general practitioners. They suggest patients should ask their GP about eligibility and availability, framing the urine test as an alternative or complement to established risk checks such as cholesterol testing.
Both sources present the same core message: the test could help detect risk earlier than standard clinical measures and potentially allow earlier prevention. However, the reporting differs mainly in emphasis, with one outlet foregrounding the “as important as a cholesterol check” comparison and the other focusing on why GPs may not provide it by default. The coverage does not detail specific clinical study results or national rollout plans in the provided text.
